​

Benitec Biopharma Ownership | Who Owns Benitec Biopharma?

OverviewForecastRevenueFinancialsChart

Benitec Biopharma Ownership Summary

Benitec Biopharma is owned by 23.95% institutional investors, 4.39% insiders, and 71.66% retail investors. Awm investment company is the largest institutional shareholder, holding 0% of BNTC shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 8.29% of its assets in Benitec Biopharma shares.

BNTC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBenitec Biopharma23.95%4.39%71.66%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Awm investment company---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Awm investment company---

Top Buyers

HolderShares% AssetsChange
Awm investment company---625.00K

Top Sellers

HolderShares% AssetsChange
Awm investment company---625.00K

Sold Out

HolderChange
Awm investment company-625.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241-625,000-23-1---
Sep 30, 20231-93.75%23-100.00%-0.00%--100.00%1-66.67%
Jun 30, 202316-20.00%11,055,879-4.96%392.29%2-33.33%3-57.14%
Mar 31, 202320-13.04%11,633,366-5.48%412.09%3-72.73%716.67%
Dec 31, 20222315.00%12,307,556-15.85%441.59%11-15.38%6200.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Franklin Biotechnology Discv A(acc)USD1.64M8.29%1.42M
Franklin Biotechnology Discovery A573.22K5.43%-
Vanguard Institutional Extnd Mkt Idx Tr201.22K1.02%-6.57K
Janus Henderson Hrzn Biotec E2 USD134.42K0.68%3.46K
Simplify Health Care ETF89.87K0.45%-26.67K
Fidelity Extended Market Index49.07K0.25%-5.21K
BlackRock Extended Equity Market K18.50K0.18%-8.00
NT Ext Equity Mkt Idx Fd - NL14.55K0.14%-
NT Ext Equity Mkt Idx Fd - DC - NL - T211.72K0.11%36.00
Northern Trust Extended Eq Market Idx9.77K0.09%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 03, 2024SUVRETTA CAPITAL MANAGEMENT, LLC Buy$46.18K
Dec 03, 2024SUVRETTA CAPITAL MANAGEMENT, LLC Buy$357.02K
Nov 19, 2024SUVRETTA CAPITAL MANAGEMENT, LLC Buy$15.28K
Nov 20, 2024SUVRETTA CAPITAL MANAGEMENT, LLC Buy$248.96K
Nov 19, 2024SUVRETTA CAPITAL MANAGEMENT, LLC Buy$120.94K

Insider Transactions Trends

DateBuySell
2024 Q46-
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--

BNTC Ownership FAQ

Who Owns Benitec Biopharma?

Benitec Biopharma shareholders are primarily institutional investors at 23.95%, followed by 4.39% insiders and 71.66% retail investors. The average institutional ownership in Benitec Biopharma's industry, Biotech Stocks , is 47.04%, which Benitec Biopharma falls below.

Does Blackrock own Benitec Biopharma?

BlackRock is not among the top 10 institutional shareholders of Benitec Biopharma.

Who is Benitec Biopharma’s biggest shareholder by percentage of total assets invested?

Awm investment company is Benitec Biopharma’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Benitec Biopharma shares, valued at 0$.

Who is the top mutual fund holder of Benitec Biopharma shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of Benitec Biopharma shares, with 8.29% of its total shares outstanding invested in 1.64M Benitec Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools